rTNV148B IgG
Sponsors
Centocor BV, Centocor B.V., Janssen Biologics B.V.
Conditions
Active Rheumatoid Arthritis (methotrexate [MTX]-naïve)Active rheumatoid arthritis (RA)Active rheumatoid arthritis (RA) despite methotrexate (MTX) therapyAnkylosing Spondylitis (AS)Psoriatic Arthritis
Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously, in Methotrexate-naïve Subjects with Active Rheumatoid Arthritis - NA
Active, not recruitingEUCTR2004-003295-10-GB
Start: 2006-05-17Target: 600Updated: 2020-07-27
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthritis and Previously Treated with Biologic Anti-TNFalfa Agent(s) - GO-AFTER
Active, not recruitingEUCTR2005-001742-16-GB
Start: 2006-05-26Target: 420Updated: 2019-11-25
Unknown Phase
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Rheumatoid Arthritis Despite Methotrexate Therapy - NA
Active, not recruitingEUCTR2004-003296-36-DE
Start: 2006-03-29Target: 400Updated: 2012-08-21
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Psoriatic Arthritis - NA
Active, not recruitingEUCTR2004-003298-10-DE
Start: 2006-06-07Target: 396Updated: 2012-05-01
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Ankylosing Spondylitis - NA
Active, not recruitingEUCTR2004-003299-12-FI
Start: 2006-04-26Target: 345Updated: 2012-05-01